Astroglia are key cellular sites where opiate drug signals converge with the proinflammatory effects of HIV-1 Tat signals to exacerbate HIV encephalitis. Despite this understanding, the molecular sites of convergence driving opiate-accelerated neuropathogenesis have not been deciphered. We therefore explored potential points of interaction between the signaling pathways initiated by HIV-1 Tat and opioids in striatal astrocytes. Profiling studies screening 152 transcription factors indicated that the nuclear factor-kappa B (NF-kB) subunit, c-Rel, was a likely candidate for Tat or Tat plus opiate-induced increases in cytokine and chemokine production by astrocytes. Pretreatment with the NF-kB inhibitor parthenolide provided evidence that Tat6...
BACKGROUND: Human immunodeficiency virus type-1 (HIV-1) and opiates cause long-term inflammatory ins...
Abstract: Few preclinical studies have compared the relative therapeutic efficacy of medications use...
BackgroundHIV-associated neurocognitive disorders (HANDs) afflict more than half of HIV-1-positive i...
Despite antiretroviral therapy human immunodeficiency virus type-1 (HIV-1) infection results in neur...
Abstract Background The collective cognitive and motor deficits known as HIV-associated neurocogniti...
Human immunodeficiency virus type 1 (HIV-1) persists in certain CNS cell populations, despite periph...
A number of human immunodeficiency virus type-1 (HIV) positive subjects are also opiate abusers. The...
Early in infection, HIV crosses the blood-brain barrier and induces neuropathology. Viral presence i...
HIV-1 enters the CNS soon after initial systemic infection; within the CNS parenchyma infected and/o...
HIV-1 infection is highly comorbid with opioid use disorder. Prescription and illicit use of opioids...
<p>Cells were pretreated with vehicle or leptomycin B (LMB) followed by 30 min, 2 or 6 h treatment (...
Nearly one−half of people infected with Human immunodeficiency virus type 1 (HIV−1) experience HIV-a...
Despite combination antiretroviral therapy effectively suppressing HIV within the periphery, the cen...
Neurocognitive impairments affect a substantial population of HIV-1 infected individuals despite the...
<div><p>Neurocognitive impairments affect a substantial population of HIV-1 infected individuals des...
BACKGROUND: Human immunodeficiency virus type-1 (HIV-1) and opiates cause long-term inflammatory ins...
Abstract: Few preclinical studies have compared the relative therapeutic efficacy of medications use...
BackgroundHIV-associated neurocognitive disorders (HANDs) afflict more than half of HIV-1-positive i...
Despite antiretroviral therapy human immunodeficiency virus type-1 (HIV-1) infection results in neur...
Abstract Background The collective cognitive and motor deficits known as HIV-associated neurocogniti...
Human immunodeficiency virus type 1 (HIV-1) persists in certain CNS cell populations, despite periph...
A number of human immunodeficiency virus type-1 (HIV) positive subjects are also opiate abusers. The...
Early in infection, HIV crosses the blood-brain barrier and induces neuropathology. Viral presence i...
HIV-1 enters the CNS soon after initial systemic infection; within the CNS parenchyma infected and/o...
HIV-1 infection is highly comorbid with opioid use disorder. Prescription and illicit use of opioids...
<p>Cells were pretreated with vehicle or leptomycin B (LMB) followed by 30 min, 2 or 6 h treatment (...
Nearly one−half of people infected with Human immunodeficiency virus type 1 (HIV−1) experience HIV-a...
Despite combination antiretroviral therapy effectively suppressing HIV within the periphery, the cen...
Neurocognitive impairments affect a substantial population of HIV-1 infected individuals despite the...
<div><p>Neurocognitive impairments affect a substantial population of HIV-1 infected individuals des...
BACKGROUND: Human immunodeficiency virus type-1 (HIV-1) and opiates cause long-term inflammatory ins...
Abstract: Few preclinical studies have compared the relative therapeutic efficacy of medications use...
BackgroundHIV-associated neurocognitive disorders (HANDs) afflict more than half of HIV-1-positive i...